516 related articles for article (PubMed ID: 16462491)
1. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
2. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
Hsu AR; Cai W; Veeravagu A; Mohamedali KA; Chen K; Kim S; Vogel H; Hou LC; Tse V; Rosenblum MG; Chen X
J Nucl Med; 2007 Mar; 48(3):445-54. PubMed ID: 17332623
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy.
Inoue Y; Izawa K; Tojo A; Nomura Y; Sekine R; Oyaizu N; Ohtomo K
Exp Hematol; 2007 Mar; 35(3):407-15. PubMed ID: 17309821
[TBL] [Abstract][Full Text] [Related]
4. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
[TBL] [Abstract][Full Text] [Related]
5. A novel rat model for glioblastoma multiforme using a bioluminescent F98 cell line.
Bryant MJ; Chuah TL; Luff J; Lavin MF; Walker DG
J Clin Neurosci; 2008 May; 15(5):545-51. PubMed ID: 18378459
[TBL] [Abstract][Full Text] [Related]
6. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
[TBL] [Abstract][Full Text] [Related]
7. In vivo bioluminescence imaging.
Sato A; Klaunberg B; Tolwani R
Comp Med; 2004 Dec; 54(6):631-4. PubMed ID: 15679260
[TBL] [Abstract][Full Text] [Related]
8. Integrated imaging approach to tumor model mice using bioluminescence imaging and magnetic resonance imaging.
Inoue Y; Masutani Y; Kiryu S; Haishi T; Watanabe M; Tojo A; Ohtomo K
Mol Imaging; 2010 Jun; 9(3):163-72. PubMed ID: 20487682
[TBL] [Abstract][Full Text] [Related]
9. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
10. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
Kim B; Chenevert TL; Ross BD
Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice.
Wang Y; Iyer M; Annala A; Wu L; Carey M; Gambhir SS
Physiol Genomics; 2006 Jan; 24(2):173-80. PubMed ID: 16410544
[TBL] [Abstract][Full Text] [Related]
13. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
14. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.
Hsu AR; Hou LC; Veeravagu A; Greve JM; Vogel H; Tse V; Chen X
Mol Imaging Biol; 2006; 8(6):315-23. PubMed ID: 17053862
[TBL] [Abstract][Full Text] [Related]
15. Effect of the angiogenesis inhibitor Cilengitide (EMD 121974) on glioblastoma growth in nude mice.
Yamada S; Bu XY; Khankaldyyan V; Gonzales-Gomez I; McComb JG; Laug WE
Neurosurgery; 2006 Dec; 59(6):1304-12; discussion 1312. PubMed ID: 17277694
[TBL] [Abstract][Full Text] [Related]
16. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
17. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Canron X; Bikfalvi A; Martuza RL; Kurtz A; Rabkin SD
Clin Cancer Res; 2006 Nov; 12(22):6791-9. PubMed ID: 17121900
[TBL] [Abstract][Full Text] [Related]
18. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
19. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
[TBL] [Abstract][Full Text] [Related]
20. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.
Bouvet M; Spernyak J; Katz MH; Mazurchuk RV; Takimoto S; Bernacki R; Rustum YM; Moossa AR; Hoffman RM
Cancer Res; 2005 Nov; 65(21):9829-33. PubMed ID: 16267005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]